May. 16, 2014
The US biopesticide company Marrone Bio Innovations (MBI) recorded a 2.2% increase in sales to around $2.8 million in the first quarter of 2014. Product sales decreased by 11.6% to some $ 2.1 million in this quarter, while related party revenues grew by some 110% to $309,000. Licensing revenues dropped by 6.3% to $45,000. The result is in line with the company's expectations against the headwinds of severe weather in all growing regions, the company notes.
MBI's sales results($ 000)
|
|||
Q1 ended Mar 31
|
Q1 2014
|
Q1 2013
|
% change
|
Revenues
|
2,790
|
2,730
|
+2.2
|
Products
|
2,097
|
2,373
|
-11.6
|
Licensing
|
45
|
48
|
-6.3
|
Related party
|
648
|
309
|
109.7
|
Gross profit
|
1,138
|
935
|
+21.7
|
Net profit (loss)
|
(10,246)
|
(10,749)
|
-
|
Subscribe Email: | * | |
Name: | ||
Mobile Number: | ||
0/1200